CANCER, a peer-reviewed journal of the American Cancer Society, has announced that Dr. Suresh S. Ramalingam will join the journal as the new editor-in-chief, with a 5-year editorship beginning July 1, 2021. Dr. Ramalingam is internationally recognized for his research, specifically for the development of individualized therapies for patients with small cell and non-small cell lung cancer.
Currently, Dr. Ramalingam is deputy director of Winship Cancer Institute of Emory University, where he leads the integration of the research, clinical, and educational components, and is assistant dean for cancer research at Emory University School of Medicine. He has worked with CANCER as the editor for the journal’s Chest and Lung Disease, Clinical Trials, and Medical Oncology sections since 2011.
Dr. Ramalingam succeeds Dr. Khuri, who leaves the editor-in-chief position after 10 years of providing vision, leadership, and dedicated service to help increase the journal’s visibility among some of the top research journals in the field. During his tenure, submissions to CANCER increased by over 40% and full-text accesses to the journal’s online content more than doubled, making it the most downloaded medical journal on Wiley Online Library.
Dr. Ramalingam holds additional titles at Emory University School of Medicine including professor of hematology and medical oncology, director of the Division of Medical Oncology, and the Roberto C. Goizueta Distinguished Chair for Cancer Research.
CANCER is a peer-reviewed publication of the American Cancer Society integrating scientific information from worldwide sources for all oncologic specialties. The journal aims to provide an interdisciplinary forum for the exchange of information among oncologic disciplines concerned with the etiology, course, and treatment of human cancer. CANCER is published on behalf of the American Cancer Society by Wiley and can be accessed online.
Click here to read the original press release.
